3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Unknown
1
Sponsor Class
NETWORK
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Uterine Cervical Neoplasms
5
Medulloblastoma
5
Neuroblastoma
4
Squamous Cell Carcinoma of Head and Neck
3
Mouth Neoplasms
3
Laryngeal Neoplasms
3
Hypopharyngeal Neoplasms
3
Ganglioneuroblastoma
3
Carcinoma
3
Vulvar Neoplasms
2
Gallbladder Neoplasms
2
Carcinoma, Non-Small-Cell Lung
2
Vomiting
1
Teratoma
1
Stage III Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma AJCC v6 and v7
1
Stage I Nasopharyngeal Keratinizing Squamous Cell Carcinoma AJCC v7
1
Sertoli-Leydig Cell Tumor
1
Rhabdoid Tumor
1
Recurrent Uterine Corpus Carcinoma
1
Ovarian gynandroblastoma
1
Ovarian Neoplasms
1
Osteosarcoma
1
Oropharyngeal Neoplasms
1
Neoplasms, Germ Cell and Embryonal
1
Nausea
1
Lymphoid Interstitial Pneumonia
1
Hodgkin Disease
1
Hepatoblastoma
1
HIV Infections
1
Granulosa cell tumor of the ovary
1
Interventions
Fluorouracil
6
Cisplatin
4
Radiotherapy
3
Mitomycin
3
dehydroftorafur
2
Radiotherapy, Intensity-Modulated
2
Cetuximab
2
Capecitabine
2
Taxes
1
Specimen Handling
1
Platinum
1
Paclitaxel
1
Mitozytrex
1
Magnetic Resonance Spectroscopy
1
Fluorodeoxyglucose F18
1
Carboplatin
1
Biopsy
1
1,2-diaminocyclohexaneplatinum II citrate
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
NETWORK
×
Anal Canal Carcinoma
×
1,2-diaminocyclohexaneplatinum II citrate
×
Clear all
NCT02560298
2023-06-22
InterAACT
Eastern Cooperative Oncology Group
Phase 2
Unknown
91 enrolled